Literature DB >> 9740106

Polynitroxyl albumin reduces infarct size in transient focal cerebral ischemia in the rat: potential mechanisms studied by magnetic resonance imaging.

C Beaulieu1, E Busch, J Röther, A de Crespigny, C J Hsia, M E Moseley.   

Abstract

Nitroxide free radicals are known to protect cells from oxidative damage. Diffusion-weighted and perfusion-weighted magnetic resonance imaging was used to evaluate the effects of polynitroxyl albumin (PNA) in a middle cerebral artery intraluminal suture model of transient focal cerebral ischemia in the rat. Three groups of Sprague-Dawley rats were investigated: (1) PNA (N=6), (2) human serum albumin (N =6), and (3) saline (N=7). The middle cerebral artery was occluded for 2 hours. Treatment was started 30 minutes after induction of ischemia. A total dose of 1% body weight (volume/weight) of PNA (23.5 mg/dL protein and 110 mmol/L nitroxide), albumin (23.5 mg/dL), or saline was injected intravenously at three time points: 0.5% at 0.5 hours, 0.25% at 2 hours (i.e., just before reperfusion), and 0.25% at 4 hours after occlusion. Six sets of diffusion- and perfusion-weighted magnetic resonance images were acquired throughout the 2 hours of ischemia and the 2 hours of reperfusion. The rats were killed at 24 hours, and the brains were stained with 2,3,5-triphenyltetrazolium chloride (TTC). Diffusion-weighted imaging showed that the growth of the ischemic lesion was suppressed in the PNA-treated group. The 4 hours diffusion-weighted imaging--derived hemispheric lesion volume in the PNA-treated group (25%+/-9%) was significantly smaller than that in the saline-treated (43%+/-13%; P=0.016) or albumin-treated groups (38%+/-6%; P=0.017). A larger difference was observed for the 24-hour TTC-derived lesion volumes in the PNA (8%+/-7%), saline (35%+/-8%; P < 0.001), and albumin (31%+/-6%; P < 0.001) groups. Perfusion-weighted imaging demonstrated a marked improvement in cerebral perfusion in the PNA-treated group during ischemia and reperfusion. In conclusion, treatment with PNA results in an improvement in perfusion and a reduction of infarct volume in a model of transient focal cerebral ischemia in the rat.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9740106     DOI: 10.1097/00004647-199809000-00012

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  6 in total

1.  Polynitroxyl albumin and albumin therapy after pediatric asphyxial cardiac arrest: effects on cerebral blood flow and neurologic outcome.

Authors:  Mioara D Manole; Patrick M Kochanek; Lesley M Foley; T Kevin Hitchens; Hülya Bayır; Henry Alexander; Robert Garman; Li Ma; Carleton J C Hsia; Chien Ho; Robert S B Clark
Journal:  J Cereb Blood Flow Metab       Date:  2011-11-30       Impact factor: 6.200

2.  Polynitroxylated pegylated hemoglobin: a novel neuroprotective hemoglobin for acute volume-limited fluid resuscitation after combined traumatic brain injury and hemorrhagic hypotension in mice.

Authors:  David K Shellington; Lina Du; Xianren Wu; Jennifer Exo; Vincent Vagni; Li Ma; Keri Janesko-Feldman; Robert S B Clark; Hülya Bayir; C Edward Dixon; Larry W Jenkins; Carleton J C Hsia; Patrick M Kochanek
Journal:  Crit Care Med       Date:  2011-03       Impact factor: 7.598

3.  Resuscitation of traumatic brain injury and hemorrhagic shock with polynitroxylated albumin, hextend, hypertonic saline, and lactated Ringer's: Effects on acute hemodynamics, survival, and neuronal death in mice.

Authors:  Jennifer L Exo; David K Shellington; Hülya Bayir; Vincent A Vagni; Keri Janesco-Feldman; Lil Ma; Carleton J Hsia; Robert S B Clark; Larry W Jenkins; C Edward Dixon; Patrick M Kochanek
Journal:  J Neurotrauma       Date:  2009-12       Impact factor: 5.269

4.  Characterizing the diffusion/perfusion mismatch in experimental focal cerebral ischemia.

Authors:  Xiangjun Meng; Marc Fisher; Qiang Shen; Christopher H Sotak; Timothy Q Duong
Journal:  Ann Neurol       Date:  2004-02       Impact factor: 10.422

5.  The neuroprotective effect of prostaglandin E2 EP1 receptor inhibition has a wide therapeutic window, is sustained in time and is not sexually dimorphic.

Authors:  Takato Abe; Alexander Kunz; Munehisa Shimamura; Ping Zhou; Josef Anrather; Costantino Iadecola
Journal:  J Cereb Blood Flow Metab       Date:  2008-07-23       Impact factor: 6.200

6.  Transfusion of Polynitroxylated Pegylated Hemoglobin Stabilizes Pial Arterial Dilation and Decreases Infarct Volume After Transient Middle Cerebral Artery Occlusion.

Authors:  Suyi Cao; Jian Zhang; Li Ma; Carleton J C Hsia; Raymond C Koehler
Journal:  J Am Heart Assoc       Date:  2017-09-12       Impact factor: 5.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.